BIM-21863

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBIM-21863
Drug Alias Nameghrelin receptor antagonistBIM-21863
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen Inc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A